On the other hand, experimental data suggest that ACE2 expression is reduced in late-stage DM [39] and SARS-CoV2 infection may also downregulate ACE2 expression, predisposing patients to severe complications and adverse outcomes [63]. The gene discussed is ACE2; the disease is diabetes mellitus.